Showing results (151-160 of 10,339) with videos related to
Sort By:
Pageof 1,034
Annals of the Rheumatic Diseases|June 7, 2017
Comparative effectiveness of allopurinol versus febuxostat for preventing incident renal disease in older adults: an analysis of Medicare claims dataJasvinder A Singh, John D ClevelandAnnals of the Rheumatic Diseases|September 11, 2016
International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trialsAna-Maria Orbai, Maarten de Wit, Philip Mease, et al.Annals of the Rheumatic Diseases|September 11, 2016
T cell subsets: an immunological biomarker to predict progression to clinical arthritis in ACPA-positive individualsL Hunt, E M Hensor, J Nam, et al.Annals of the Rheumatic Diseases|February 1, 1985
A rheumatological dilemma: is it possible to modify the course of rheumatoid arthritis? Can we answer the question?T Pullar, H A CapellAnnals of the Rheumatic Diseases|June 14, 2017
Long-term outcomes after disease activity-guided dose reduction of TNF inhibition in rheumatoid arthritis: 3-year data of the DRESS study - a randomised controlled pragmatic non-inferiority strategy trialChantal Am Bouman, Noortje van Herwaarden, Frank Hj van den Hoogen, et al.Annals of the Rheumatic Diseases|June 14, 2017
Differences in the symptomatic phase preceding ACPA-positive and ACPA-negative RA: a longitudinal study in arthralgia during progression to clinical arthritisLeonie E Burgers, Hanna W van Steenbergen, Robin M Ten Brinck, et al.Annals of the Rheumatic Diseases|June 14, 2017
Faecal microbiota study reveals specific dysbiosis in spondyloarthritisMaxime Breban, Julien Tap, Ariane Leboime, et al.Annals of the Rheumatic Diseases|June 14, 2017
The dynamics of response as measured by multiple composite outcome tools in the TIght COntrol of inflammation in early Psoriatic Arthritis (TICOPA) trialLaura C Coates, Farrouq Mahmood, Paul Emery, et al.Annals of the Rheumatic Diseases|February 11, 2022
Proteogenomic analysis of the autoreactive B cell repertoire in blood and tissues of patients with Sjögren's syndromeMathijs G A Broeren, Jing J Wang, Giulia Balzaretti, et al.Annals of the Rheumatic Diseases|October 7, 2021
B-cell depletion with obinutuzumab for the treatment of proliferative lupus nephritis: a randomised, double-blind, placebo-controlled trialRichard A Furie, Gustavo Aroca, Matthew D Cascino, et al.Pageof 1,034